Pfizer deal allows COVID pill distribution in developing countries
Pfizer has struck a deal to allow the production and distribution of a generic version of its COVID-19 treatment pill. Early November clinical trial results suggest the pill slashes risks of hospitalization and even death by 89 per cent among at-risk adults. A deal struck between vaccine manufacturer Pfizer and UN-backed not-for-profit organisations Medicines Patent…